Literature DB >> 6954876

Activity of N-formimidoyl thienamycin and cephalosporins against isolates from nosocomially acquired bacteremia.

J Gutiérrez-Núñez, P T Harrington, C H Ramirez-Ronda.   

Abstract

The in vitro activity of N-formimidoyl thienamycin was compared with that of seven beta-lactam agents against bacteremic clinical isolates, including gentamicin-resistant, gram-negative bacilli, Staphylococcus aureus, Staphylococcus epidermidis, streptococci, and enterococci. N-formimidoyl thienamycin was the most active antibiotic against all of the gram-positive cocci studied, with the exception of Staphylococcus epidermidis, and the only agent active against the enterococci. N-formimidoyl thienamycin was less active than some of the other agents against Enterobacteriaceae, except for the strains of Serratia and Citrobacter studied. For Pseudomonas aeruginosa, N-formimidoyl thienamycin was the most active agent (4 micrograms/ml was the lowest concentration that inhibited 90% of the strains tested).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6954876      PMCID: PMC181925          DOI: 10.1128/AAC.21.3.509

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  Thienamycin: new beta-lactam antibiotic with potent broad-spectrum activity.

Authors:  S S Weaver; G P Bodey; B M LeBlanc
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191

2.  In vitro activity of thienamycin.

Authors:  F P Tally; N V Jacobus; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

3.  Evaluation of a dispensing instrument (Dynatech MIC-2000) for preparing microtiter antibiotic plates and testing their potency during storage.

Authors:  P R McMaster; E A Robertson; F G Witebsky; J D MacLowry
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

4.  MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities.

Authors:  H Kropp; J G Sundelof; J S Kahan; F M Kahan; J Birnbaum
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

5.  In vitro activity of N-formimidoyl thienamycin (MK0787).

Authors:  F P Tally; N V Jacobus; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

6.  In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin.

Authors:  V W Horadam; J D Smilack; C L Montgomery; J Werringloer
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

7.  In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime.

Authors:  L Verbist; J Verhaegen
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191

  7 in total
  3 in total

1.  Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology.

Authors:  K E Aldridge; H M Wexler; C V Sanders; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

2.  Imipenem susceptibility testing with a commercially prepared dry-format microdilution tray.

Authors:  J L Staneck
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

3.  Cerebrospinal fluid penetration of imipenem and cilastatin (primaxin) in children with central nervous system infections.

Authors:  R F Jacobs; G L Kearns; A L Brown; D C Longee
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.